Associated Papers
Prevalence and therapeutic response of EGFR T790I mutation in NSCLC patients with acquired resistance to EGFR-TKIs: a retrospective cohort study.
Shi J et al.
Bmc Cancer, 2025
Identification of a Rare EGFR T790I Mutation in Lung Adenocarcinoma Sensitive to Osimertinib.
Wang Y et al.
Frontiers in Oncology, 2021
Select a paper to view details